SRP72
Basic information
Region (hg38): 4:56467617-56503681
Links
Phenotypes
GenCC
Source:
- acute myeloid leukemia (Moderate), mode of inheritance: AD
- autosomal dominant aplasia and myelodysplasia (Limited), mode of inheritance: AD
- autosomal dominant aplasia and myelodysplasia (Supportive), mode of inheritance: AD
- autosomal dominant aplasia and myelodysplasia (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Bone marrow failure syndrome 1 | AD | Audiologic/Otolaryngologic; Hematologic; Oncologic | Individuals have been described as having early-onset anemia/panyctopenia, as well as later myelodysplasia, and measures to detect and ameliorate hematologic findings may be beneficial; Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development | Audiologic/Otolaryngologic; Hematologic; Oncologic | 22541560 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SRP72 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 78 | 90 | ||||
missense | 218 | 224 | ||||
nonsense | 6 | |||||
start loss | 0 | |||||
frameshift | 12 | 12 | ||||
inframe indel | 5 | |||||
splice donor/acceptor (+/-2bp) | 7 | |||||
splice region | 13 | 14 | 1 | 28 | ||
non coding | 32 | 83 | 66 | 181 | ||
Total | 0 | 0 | 285 | 165 | 75 |
Variants in SRP72
This is a list of pathogenic ClinVar variants found in the SRP72 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-56467626-C-T | Autosomal dominant aplasia and myelodysplasia • SRP72-related disorder | Uncertain significance (Aug 03, 2020) | ||
4-56467637-T-C | Uncertain significance (Nov 07, 2023) | |||
4-56467642-A-G | Autosomal dominant aplasia and myelodysplasia | Uncertain significance (Jan 12, 2018) | ||
4-56467644-C-T | SRP72-related disorder | Likely benign (Jul 14, 2022) | ||
4-56467652-G-C | not specified | Uncertain significance (Nov 20, 2024) | ||
4-56467653-C-T | not specified | Likely benign (Dec 08, 2024) | ||
4-56467653-C-CG | SRP72-related disorder | Uncertain significance (Dec 01, 2023) | ||
4-56467654-G-A | Uncertain significance (Sep 27, 2022) | |||
4-56467654-G-C | not specified • Autosomal dominant aplasia and myelodysplasia • SRP72-related disorder | Uncertain significance (Apr 23, 2024) | ||
4-56467654-G-T | Autosomal dominant aplasia and myelodysplasia | Benign (Jan 26, 2024) | ||
4-56467655-G-A | Autosomal dominant aplasia and myelodysplasia • not specified | Conflicting classifications of pathogenicity (Nov 17, 2024) | ||
4-56467655-G-C | not specified • Autosomal dominant aplasia and myelodysplasia | Benign/Likely benign (Feb 01, 2024) | ||
4-56467655-G-T | not specified • SRP72-related disorder | Uncertain significance (Nov 25, 2024) | ||
4-56467656-G-A | not specified | Likely benign (Nov 18, 2024) | ||
4-56467656-G-C | not specified | Likely benign (Nov 26, 2024) | ||
4-56467656-G-T | Autosomal dominant aplasia and myelodysplasia | Benign (Feb 01, 2024) | ||
4-56467657-G-A | Uncertain significance (Oct 01, 2022) | |||
4-56467657-G-C | Uncertain significance (Dec 07, 2023) | |||
4-56467658-G-A | Autosomal dominant aplasia and myelodysplasia • not specified | Conflicting classifications of pathogenicity (Oct 02, 2024) | ||
4-56467658-G-C | not specified | Uncertain significance (Nov 22, 2024) | ||
4-56467659-G-A | Likely benign (Dec 11, 2023) | |||
4-56467659-G-C | not specified | Likely benign (Dec 06, 2024) | ||
4-56467659-G-T | Likely benign (Nov 01, 2022) | |||
4-56467659-GG-T | Uncertain significance (Nov 14, 2022) | |||
4-56467660-G-A | SRP72-related disorder | Uncertain significance (Dec 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SRP72 | protein_coding | protein_coding | ENST00000342756 | 19 | 36759 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00171 | 0.998 | 125714 | 0 | 34 | 125748 | 0.000135 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.02 | 294 | 347 | 0.846 | 0.0000174 | 4381 |
Missense in Polyphen | 65 | 93.623 | 0.69427 | 1285 | ||
Synonymous | 0.948 | 108 | 121 | 0.890 | 0.00000582 | 1232 |
Loss of Function | 4.13 | 13 | 41.8 | 0.311 | 0.00000211 | 512 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000519 | 0.000518 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000173 | 0.000163 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000134 | 0.000132 |
Middle Eastern | 0.000173 | 0.000163 |
South Asian | 0.0000655 | 0.0000653 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Signal-recognition-particle assembly has a crucial role in targeting secretory proteins to the rough endoplasmic reticulum membrane. Binds the 7S RNA only in presence of SRP68. This ribonucleoprotein complex might interact directly with the docking protein in the ER membrane and possibly participate in the elongation arrest function.;
- Disease
- DISEASE: Bone marrow failure syndrome 1 (BMFS1) [MIM:614675]: An autosomal dominant disease characterized by aplastic anemia and myelodysplasia resulting from bone marrow failure. Aplastic anemia is a form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. Myelodysplasia is a clonal hematopoietic stem cell disorder in which immature cells in the bone marrow become malformed and dysfunctional. {ECO:0000269|PubMed:22541560}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Protein export - Homo sapiens (human);SRP-dependent cotranslational protein targeting to membrane;Translation;Metabolism of proteins
(Consensus)
Recessive Scores
- pRec
- 0.137
Intolerance Scores
- loftool
- 0.482
- rvis_EVS
- -0.6
- rvis_percentile_EVS
- 18.06
Haploinsufficiency Scores
- pHI
- 0.739
- hipred
- Y
- hipred_score
- 0.602
- ghis
- 0.680
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.896
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Srp72
- Phenotype
Gene ontology
- Biological process
- SRP-dependent cotranslational protein targeting to membrane;SRP-dependent cotranslational protein targeting to membrane, translocation;response to drug
- Cellular component
- endoplasmic reticulum;signal recognition particle, endoplasmic reticulum targeting;cytosol;signal recognition particle
- Molecular function
- RNA binding;signal recognition particle binding;protein binding;7S RNA binding;TPR domain binding;ribosome binding